NIMH FOAs
PA-20-144: Innovations in HIV Prevention, Testing, Adherence and Retention to Optimize HIV Prevention and Care Continuum Outcomes (R01 Clinical Trial Optional)
RFA-MH-22-230: Understanding the role of the Gut Immune dysfunction and Gut Microbiome in pathogenesis of Central Nervous System co-morbidities in people living with HIV (R21 Clinical Trial Not Allowed)
RFA-MH-22-280: Epigenetic Mechanisms Regulating HIV CNS Latency and Neuropathologies Using Novel Single Cell Technologies (R01 Clinical Trial Not Allowed)
RFA-MH-22-190: Expanding Collaborative Implementation Science to Address Social and Structural Determinants of Health and Improve HIV Outcomes (R01 Clinical Trial Required)
NOT-CA-22-037: Notice of Special Interest (NOSI): Validation of Digital Health and Artificial Intelligence Tools for Improved Assessment in Epidemiological, Clinical, and Intervention Research
RFA-MH-22-191: Expanding Collaborative Implementation Science to Address Social and Structural Determinants of Health and Improve HIV Outcomes (R24 Clinical Trial Not Allowed)
NOT-MH-20-035: Notice of Special Interest (NOSI): Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults
NOT-MH-21-105: Notice of Special Interest (NOSI): Advancing Health Communication Research on HIV Prevention, Treatment and Cure
NOT-MH-20-013: Notice of Special Interest (NOSI): Mental Health Comorbidities in HIV Prevention and Treatment
NOT-MH-20-019: Notice of Special Interest (NOSI): Strengthening the HIV Prevention Continuum
NOT-MH-20-020: Notice of Special Interest: Stigma or Other Social Determinants of Health (SDOH) in HIV Prevention and Treatment
NOT-MH-20-023: Notice of Special Interest (NOSI): Strengthening the HIV Care Continuum
NOT-MH-20-024: Notice of Special Interest (NOSI): Implementation Science to Advance the United States HIV Prevention and Treatment Goals and the Global HIV Prevention and Treatment Targets
NOT-MH-20-035: Notice of Special Interest (NOSI): Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults
NOT-MH-21-105: Notice of Special Interest (NOSI): Advancing Health Communication Research on HIV Prevention, Treatment, and Cure
NOT-MH-22-095: Notice of Special Interest (NOSI): NIMH Priorities on Research on Aggression and Violence Against Others
PA-20-144: Innovations in HIV Prevention, Testing, Adherence and Retention to Optimize HIV Prevention and Care Continuum Outcomes (R01 Clinical Trial Optional)
PA-20-141: Formative and Pilot Intervention Research for Prevention and Treatment of HIV/AIDS (R34 Clinical Trial Optional)
PA-20-145: Innovations in HIV Prevention, Testing, Adherence and Retention to Optimize HIV Prevention and Care Continuum Outcomes (R21 Clinical Trial Optional)
PAR-20-307: Developmental AIDS Research Centers on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
PAR-21-228: NIMH Research Education Mentoring Program for HIV/AIDS Researchers (R25 Clinical Trial Not Allowed)
PAR-20-308: AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
PAR-20-151: Eradication of HIV-1 from Central Nervous system Reservoirs (R01 Clinical Trial Not Allowed)
PAR-20-149: HIV Infection of the Central Nervous System (R01 Clinical Trial Not Allowed)
RFA-MH-22-170: Advancing communication strategies to support future HIV vaccine use (R01 Clinical Trial Optional)
RFA-MH-22-171: Advancing communication strategies to support future HIV vaccine use (R21 Clinical Trial Optional)
Co-Sponsored FOAs
NOT-AI-21-054: Notice of Special Interest (NOSI): Harnessing Big Data to Halt HIV
NOT-AI-21-057: Notice of Special Interest (NOSI) HIV/AIDS in the Era of COVID-19: When Pandemics Collide
NOT-CA-22-037: Notice of Special Interest (NOSI): Validation of Digital Health and Artificial Intelligence Tools for Improved Assessment in Epidemiological, Clinical, and Intervention Research
NOT-OD-22-069: Notice of Special Interest (NOSI): Support for existing data repositories to align with FAIR and TRUST principles and evaluate usage, utility, and impact
NOT-OD-22-065: Notice of Special Interest (NOSI): Administrative Supplements for Advancing the Ethical Development and Use of AI/ML in Biomedical and Behavioral Sciences
NOT-OD-22-067: Notice of Special Interest (NOSI): Administrative Supplements to Support Collaborations to Improve the AI/ML-Readiness of NIH-Supported Data
NOT-OD-22-068: Notice of Special Interest (NOSI): Administrative Supplements to Support Enhancement of Software Tools for Open Science
NOT-DA-21-060: Notice of Special Interest (NOSI): Reducing Stigma Related to Drug Use in Human Service Settings
NOT-OD-21-100: Notice of Special Interest (NOSI): Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health
NOT-MD-22-006: Notice of Special Interest (NOSI): Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities
NOT-AI-21-011: Notice of Special Interest (NOSI): Secondary Analysis of Existing Datasets for Advancing Immune-mediated and Infectious Disease Research
NOT-CA-22-037: Validation of Digital Health and Artificial Intelligence Tools for Improved Assessment in Epidemiological, Clinical, and Intervention Research
NOT-MH-22-095: Notice of Special Interest: NIMH Priorities on Aggression and Violence Against Others
PAR-21-303: Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional)
PAR-21-068: Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)
PAR-20-036: Getting To Zero: Understanding HIV Viral Suppression and Transmission in the United States (R01 Clinical Trial Optional)
PAR-21-344: Interventions for Stigma Reduction to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle- Income Countries (R01 - Clinical Trial Optional)
PAR-21-297: Novel Systemic Options for Young Adults under the tab PA-Joint; Multipurpose Prevention Technology
PAR-21-070: Detection of HIV for Self-Testing (R61/R33 Clinical Trial Not Allowed)
PAR-21-297: Multipurpose Prevention Technology: Novel Systemic Options for Young Adults
